Tocqueville Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Tocqueville Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,800	Closed	-$340K	–	830
2016 Q3	$340K	Sell	2,800 -9,650	-78%	-$1.3M	﹤0.01%	689
2016 Q2	$1.76M	Buy	12,450 +8,750	+236%	+$1.29M	0.02%	431
2016 Q1	$483K	Buy	+3,700	New	+$461K	0.01%	643
2015 Q3	–	Sell	-2,400	Closed	-$423K	–	988
2015 Q2	$423K	Hold	2,400	–	–	0.01%	759
2015 Q1	$415K	Sell	2,400 -572	-19%	-$98.2K	﹤0.01%	753
2014 Q4	$487K	Sell	2,972 -430	-13%	-$71.4K	0.01%	712
2014 Q3	$546K	Sell	3,402 -4,373	-56%	-$672K	0.01%	599
2014 Q2	$1.14M	Buy	7,775 +412	+6%	+$57.1K	0.01%	554
2014 Q1	$1.02M	Buy	7,363 +738	+11%	+$111K	0.01%	451
2013 Q4	$838K	Buy	+6,625	New	+$686K	0.01%	476

Other funds holding JAZZ

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Tocqueville Asset Management's JAZZ Position: Q4 2016 in Review

Tocqueville Asset Management sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2016, closing a stake of 2,800 shares — an estimated $340K sold.

Tocqueville Asset Management first reported a position in JAZZ in Q4 2013 and held it in 10 quarters. The position peaked at $1.76M in Q2 2016. 295 funds tracked by Wall St. Rank hold JAZZ as of Q4 2016.

Tocqueville Asset Management reported no remaining Jazz Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Tocqueville Asset Management sold 2,800 Jazz Pharmaceuticals shares in Q4 2016, an estimated $340K.
Tocqueville Asset Management first reported a position in Jazz Pharmaceuticals in Q4 2013 and held it in 10 quarters.
Tocqueville Asset Management's Jazz Pharmaceuticals position peaked at $1.76M in Q2 2016.
295 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2016.

Based on Tocqueville Asset Management's 13F filing for Q4 2016, filed 30 Jan 2017.